Goldman Sachs’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Goldman Sachs’s Portfolio ORGS Stock Details ORGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,964	Closed	-$100K	–	6575
2021 Q2	$100K	Buy	1,964 +573	+41%	+$28.9K	﹤0.01%	5946
2021 Q1	$80K	Buy	+1,391	New	+$90.6K	﹤0.01%	5883
2020 Q3	–	Sell	-1,686	Closed	-$103K	–	5575
2020 Q2	$103K	Buy	+1,686	New	+$102K	﹤0.01%	4989

Other funds holding ORGS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs's ORGS Position: Q3 2021 in Review

Goldman Sachs sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2021, closing a stake of 1,964 shares — an estimated $100K sold.

Goldman Sachs first reported a position in ORGS in Q2 2020 and held it in 3 quarters. The position peaked at $103K in Q2 2020. 26 funds tracked by Wall St. Rank hold ORGS as of Q3 2021.

Goldman Sachs reported no remaining Orgenesis Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Goldman Sachs sold 1,964 Orgenesis Inc. Common Stock shares in Q3 2021, an estimated $100K.
Goldman Sachs first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Goldman Sachs's Orgenesis Inc. Common Stock position peaked at $103K in Q2 2020.
26 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.